Pilot Prospective Open, Single-Arm Multicentre Study on Off-Label Use of Tocilizumab in Patients With Severe COVID-19
Objectives: No agent has yet been proven to be effective for the treatment of patients with severe COVID-19. Methods: We conducted a pilot prospective open, single-arm multicentre study on off-label use of tocilizumab (TCZ) involving 63 hospitalised adult patients (56 males, age 62.6±12.5) with s...
| Autor principal: | |
|---|---|
| Formato: | Published Article |
| Publicado: |
2020-05-01
|
| Materias: | |
| Acceso en línea: | https://www.clinexprheumatol.org/abstract.asp?a=15723 https://hdl.handle.net/20.500.12663/1420 |